海外の治験の状況「脳卒中」での検索結果
21件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 国名
- 登録日
Authorised
- Darbepoetin for neonatal stroke
- Perinatal Arterial Ischemic Stroke (PAIS) br> ;Therapeutic area: Diseases [C] - Nervous System Diseases [C10]
- Canada, Netherlands
- 2016-11-22
Authorised
- To determine if GSK249320 helps improve recovery in patients who have had a stroke
- Stroke br>MedDRA version: 14.1 Level: LLT Classification code 10042244 Term: Stroke System Organ Class: 100000004852 ;Therapeutic area: Diseases [C] - Nervous System Diseases [C10]
- Canada, Germany, United Kingdom, United States
- 2013-01-14
Authorised
- Study to investigate if the study drug ticagrelor and ASA is more effective than Placebo (inactive tablet) and ASA in preventing new stroke events.
- Ischaemic stroke, transient ischaemic attack MedDRA version: 20.1 Level: LLT Classification code 10055221 Term: Ischemic stroke System Organ Class: 100000004852 ;Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
- Argentina, Australia, Belgium, Brazil, Bulgaria, Canada, Chile, China, Czech Republic, France, Germany, Hong Kong, Hungary, India, Italy, Korea, Republic of, Mexico, Peru, Poland, Romania, Russian Federation, Slovakia, Spain, Sweden, Taiwan, Thailand, Ukraine, Vietnam
- 2017-10-02
Authorised
- A Phase 1b/2 study to assess the safety, pharmacokinetics, and pharmacodynamics of DS-1040B in subjects with acute ischemic stroke.
- DS-1040b is an inhibitor of the activated form of thrombin-activatable fibrinolysis inhibitor (TAFIa) intended to be used for the treatment of thrombotic diseases including acute ischemic stroke (AIS).;Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
- Czech Republic, France, Germany, Italy, Slovakia, Spain, United Kingdom, United States
- 2015-06-29
Authorised
- Study to evaluate safety and effectiveness of NA-1 in reducing disability in stroke patients selected for mechanical clot removal procedures.
- Acute Ischemic Stroke (AIS) in adult subjects with a large intracranial arterial occlusion, a small ischemic core, and good collaterals. MedDRA version: 20.0 Level: PT Classification code 10061256 Term: Ischaemic stroke System Organ Class: 10029205 - Nervous system disorders MedDRA version: 20.1 Level: LLT Classification code 10055221 Term: Ischemic stroke System Organ Class: 10029205 - Nervous system disorders MedDRA version: 20.0 Level: LLT Classification code 10023027 Term: Ischaemic stroke NOS System Organ Class: 10029205 - Nervous system disorders MedDRA version: 20.1 Level: LLT Classification code 10074321 Term: Nonhaemorrhagic stroke System Organ Class: 10029205 - Nervous system disorders MedDRA version: 20.1 Level: LLT Classification code 10074318 Term: Nonhemorrhagic stroke System Organ Class: 10029205 - Nervous system disorders ;Therapeutic area: Diseases [C] - Nervous System Diseases [C10]
- Australia, Canada, Germany, Ireland, Korea, Republic of, Sweden, United Kingdom, United States
- 2017-12-18
Authorised
- Dabigatran etexilate for Secondary Stroke Prevention in Patients with Embolic Stroke of Undetermined Source (RE-SPECT ESUS)
- A study to compare dabigatran etexilate to acetylsalicylic acid in preventing recurrent stroke for patients that already had a stroke caused by an embolus (clot). Despite testing, it is unknown where in the body the embolus developed. MedDRA version: 18.1 Level: PT Classification code 10067167 Term: Cerebellar embolism System Organ Class: 10029205 - Nervous system disorders MedDRA version: 18.1 Level: PT Classification code 10014498 Term: Embolic stroke System Organ Class: 10029205 - Nervous system disorders MedDRA version: 18.1 Level: PT Classification code 10060839 Term: Embolic cerebral infarction System Organ Class: 10029205 - Nervous system disorders MedDRA version: 18.1 Level: PT Classification code 10074422 Term: Brain stem embolism System Organ Class: 10029205 - Nervous system disorders ;Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
- Argentina, Australia, Austria, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Croatia, Czech Republic, Estonia, European Union, France, Germany, Greece, Hong Kong, Hungary, India, Italy, Japan, Korea, Republic of, Mexico, New Zealand, Peru, Poland, Portugal, Russian Federation, Serbia, Singapore, Slovakia, Slovenia, Spain, Sweden, Switzerland, Taiwan, Thailand, United States
- 2014-09-05
Authorised
- The Use of Colchicine (an anti-inflammatory drug) in Prevention of Recurrent Stroke or heart attack after first Stroke; a randomised controlled trial
- The prevention of recurrent stroke and coronary events (fatal and non- fatal) after ischaemic stroke and transient ischaemic attack (TIA) not caused by cardiac embolism or other causes unrelated to atherosclerosis. MedDRA version: 20.0 Level: HLT Classification code 10044376 Term: Transient cerebrovascular events System Organ Class: 10029205 - Nervous system disorders MedDRA version: 20.0 Level: HLT Classification code 10008205 Term: Cerebrovascular embolism and thrombosis System Organ Class: 100000004866 MedDRA version: 20.0 Level: LLT Classification code 10023027 Term: Ischaemic stroke NOS System Organ Class: 10029205 - Nervous system disorders MedDRA version: 20.0 Level: LLT Classification code 10051615 Term: Atherosclerotic cardiovascular disease System Organ Class: 100000004866 MedDRA version: 20.0 Level: HLT Classification code 10007962 Term: Central nervous system vascular disorders NEC System Organ Class: 10029205 - Nervous system disorders MedDRA version: 20.0 Level: HLGT Classification code 10007963 Term: Central nervous system vascular disorders System Organ Class: 10029205 - Nervous system disorders ;Therapeutic area: Diseases [C] - Nervous System Diseases [C10]
- Australia, Canada, Czech Republic, Ireland, Spain, United States
- 2016-06-07
Authorised
- Treating Insulin Resistance in patient after Stroke for prevention of stroke and myocardial infarction after ischemic stroke and transient ischemic attack
- Insulin resistance in patients who have had a stroke or transient ischaemic attack;Therapeutic area: Diseases [C] - Nervous System Diseases [C10]
- Australia, Canada, Germany, Israel, Italy, United Kingdom, United States
- 2009-05-28
Authorised
- A study to test whether VI-0521 or placebo (contains no active drug substance) reduce the chances of developing health problems related to the functioning of the heart and vascular system (blood vessels), such as heart attacks or strokes.
- Cardiovascular Disease in overweight and obese subjects MedDRA version: 16.0 Level: LLT Classification code 10007648 Term: Cardiovascular disease, unspecified System Organ Class: 100000004849 ;Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
- Chile, China, Colombia, Czech Republic, Georgia, Germany, Hong Kong, Hungary, Israel, Korea, Republic of, Malaysia, Mexico, Philippines, Poland, Romania, Singapore, Slovakia, South Africa, Sweden, Taiwan, Thailand, Turkey, Ukraine, United Kingdom, United States
- 2013-07-24
Authorised
- Study of efficacy, safety and tolerability of BAF312 compared to placebo in patients with stroke due to intracerebral hemorrhage (ICH)
- Intracerebral Hemorrhage MedDRA version: 20.1 Level: LLT Classification code 10022754 Term: Intracerebral hemorrhage System Organ Class: 100000004852 ;Therapeutic area: Diseases [C] - Nervous System Diseases [C10]
- Germany, Spain, United States
- 2017-12-14
